A real-world study of pneumonitis in non-small cell lung cancer patients receiving durvalumab following concurrent chemoradiation

Authors

Neha Akkad, Washington University School of Medicine in St. Louis
Theodore S. Thomas, Washington University School of Medicine in St. Louis
Suhong Luo, Washington University School of Medicine in St. Louis
Eric Knoche, Washington University School of Medicine in St. Louis
Kristen M. Sanfilippo, Washington University School of Medicine in St. Louis
Jesse W. Keller, Washington University School of Medicine in St. Louis

Journal

Journal of Thoracic Disease

Publication Date

12-30-2023

Volume

15

Issue

12

First Page

6427

Last Page

6435

Document Type

Open Access Publication

DOI

10.21037/jtd-22-1604

Rights and Permissions

Akkad N, Thomas TS, Luo S, Knoche E, Sanfilippo KM, Keller JW. A real-world study of pneumonitis in non-small cell lung cancer patients receiving durvalumab following concurrent chemoradiation. J Thorac Dis. 2023 Dec 30;15(12):6427-6435. doi: 10.21037/jtd-22-1604. This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license).

Recommended Citation

Akkad, Neha; Thomas, Theodore S.; Luo, Suhong; Knoche, Eric; Sanfilippo, Kristen M.; and Keller, Jesse W., "A real-world study of pneumonitis in non-small cell lung cancer patients receiving durvalumab following concurrent chemoradiation." Journal of Thoracic Disease. 15, 12. 6427 - 6435. (2023).
https://digitalcommons.wustl.edu/oa_4/3156

Department

ICTS (Institute of Clinical and Translational Sciences)